Literature DB >> 1426410

Quantification of the ocular reactions to microfilaricides in the chemotherapy of onchocerciasis.

M Hero1, A C Bird, K Awadzi.   

Abstract

Severe adverse systemic and ocular reactions have complicated the chemotherapy of onchocerciasis. A method for the quantification of ocular reactions to chemotherapy has been devised at the Onchocerciasis Chemotherapy Research Centre, at Hohoe, in Ghana. Symptoms, visual function, anterior segment inflammation and disease of the posterior segment are graded. The information is entered into a computerised database which allows reaction scores to be calculated both for individual patients, and for treatment groups. This system enables comparison of adverse ocular reactions to various new chemotherapeutic regimens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426410     DOI: 10.1038/eye.1992.19

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  4 in total

Review 1.  Diethylcarbamazine in the treatment of patients with onchocerciasis.

Authors:  K Awadzi; H M Gilles
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

2.  Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.

Authors:  K Awadzi; Nicholas O Opoku; Simon K Attah; Janis K Lazdins-Helds; Annette C Kuesel
Journal:  Parasit Vectors       Date:  2015-10-09       Impact factor: 3.876

3.  Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.

Authors:  Nicholas O Opoku; Didier K Bakajika; Eric M Kanza; Hayford Howard; Germain L Mambandu; Amos Nyathirombo; Maurice M Nigo; Kambale Kasonia; Safari L Masembe; Mupenzi Mumbere; Kambale Kataliko; Jemmah P Larbelee; Mawolo Kpawor; Kpehe M Bolay; Fatorma Bolay; Sampson Asare; Simon K Attah; George Olipoh; Michel Vaillant; Christine M Halleux; Annette C Kuesel
Journal:  Lancet       Date:  2018-01-18       Impact factor: 79.321

4.  A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.

Authors:  Kwablah Awadzi; Nicholas O Opoku; Simon K Attah; Janis Lazdins-Helds; Annette C Kuesel
Journal:  PLoS Negl Trop Dis       Date:  2014-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.